EPIGENETIC INDUCTION OF MITOCHONDRIAL PROLINE SYNTHASE PYCR1 PROMOTES GASTRIC CANCER PROGRESSION BY REGULATING MITOCHONDRIAL DYNAMICS AND PURINE METABOLISM

被引：0
|
作者：
Xiao, Shiyu [1 ]
Zhou, Liya [1 ]
Yao, Xingyu [1 ]
Yin, Zhihao [1 ]
机构：
[1] Peking Univ Third Hosp, Beijing, Peoples R China
来源：
GUT | 2022年 / 71卷
关键词：
D O I：
10.1136/gutjnl-2022-IDDF.46
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
IDDF2022-A
引用
收藏
页码：A44 / A44
页数：1
相关论文
共 50 条
  • [1] SIRT3 regulates cancer cell proliferation through deacetylation of PYCR1 in proline metabolism
    Chen, Shuaiyi
    Yang, Xin
    Yu, Miao
    Wang, Zhe
    Liu, Boya
    Liu, Minghui
    Liu, Lu
    Ren, Mengmeng
    Qi, Hao
    Zou, Junhua
    Vucenik, Ivana
    Zhu, Wei-Guo
    Luo, Jianyuan
    NEOPLASIA, 2019, 21 (07): : 665 - 675
  • [2] Oncogenic IDH1 Mutations Promote Enhanced Proline Synthesis through PYCR1 to Support the Maintenance of Mitochondrial Redox Homeostasis
    Hollinshead, Kate E. R.
    Munford, Haydn
    Eales, Katherine L.
    Bardella, Chiara
    Li, Chunjie
    Escribano-Gonzalez, Cristina
    Thakker, Alpesh
    Nonnenmacher, Yannic
    Kluckova, Katarina
    Jeeves, Mark
    Murren, Robert
    Cuozzo, Federica
    Ye, Dan
    Laurenti, Giulio
    Zhu, Wei
    Hiller, Karsten
    Hodson, David J.
    Hua, Wei
    Tomlinson, Ian P.
    Ludwig, Christian
    Mao, Ying
    Tennant, Daniel A.
    CELL REPORTS, 2018, 22 (12): : 3107 - 3114
  • [3] OGDH promotes the progression of gastric cancer by regulating mitochondrial bioenergetics and Wnt/β-catenin signal pathway
    Lu, Xin
    Wu, Nan
    Yang, Wanli
    Sun, Jia
    Yan, Kemin
    Wu, Jing
    ONCOTARGETS AND THERAPY, 2019, 12 : 7489 - 7500
  • [4] Mitochondrial oxidative stress by Lon-PYCR1 maintains an immunosuppressive tumor microenvironment that promotes cancer progression and metastasis
    Kuo, Cheng-Liang
    Chou, Han-Yu
    Chiu, Yi-Chieh
    Cheng, An Ning
    Fan, Chi-Chen
    Chang, Yu-Ning
    Chen, Chung-Hsing
    Jiang, Shih Sheng
    Chen, Nien-Jung
    Lee, Alan Yueh-Luen
    CANCER LETTERS, 2020, 474 : 138 - 150
  • [5] Dysregulation of USP18/FTO/PYCR1 signaling network promotes bladder cancer development and progression
    Song, Wei
    Yang, Ke
    Luo, Jianjun
    Gao, Zhiyong
    Gao, Yunliang
    AGING-US, 2021, 13 (03): : 3909 - 3925
  • [6] PYCR1 promotes liver cancer cell growth and metastasis by regulating IRS1 expression through lactylation modification
    Wang, Haoyu
    Xu, Mu
    Zhang, Tong
    Pan, Jinkun
    Li, Chaopu
    Pan, Bei
    Zhou, Linpeng
    Huang, Yun
    Gao, Chenzi
    He, Mengping
    Xue, Yao
    Ji, Xuetao
    Zhang, Xu
    Wang, Ning
    Zhou, Hongwen
    Wang, Qian
    Li, John Zhong
    CLINICAL AND TRANSLATIONAL MEDICINE, 2024, 14 (10):
  • [7] PYRROLINE-5-CARBOXYLATE REDUCTASE 1(PYCR1) UPREGULATION CONTRIBUTES TO GASTRIC CANCER PROGRESSION AND INDICATES POOR SURVIVAL OUTCOME IN PATIENTS WITH GASTRIC CANCER
    Xiao, Shiyu
    Li, Sizhu
    Yuan, Ziying
    Zhou, Liya
    GASTROENTEROLOGY, 2019, 156 (06) : S496 - S496
  • [8] PYCR1 promotes the progression of non-small-cell lung cancer under the negative regulation of miR-488
    Wang, Dongchang
    Wang, Lingchan
    Zhang, Yu
    Yan, Zhenfeng
    Liu, Leyuan
    Chen, Gang
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 111 : 588 - 595
  • [9] Pyrroline-5-carboxylate reductase 1 (PYCR1) upregulation contributes to gastric cancer progression and indicates poor survival outcome
    Xiao, Shiyu
    Li, Sizhu
    Yuan, Ziying
    Zhou, Liya
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (15)
  • [10] CRIF1 promotes the progression of non-small-cell lung cancer by SIRT3- mediated deacetylation of PYCR1
    Qi Wang
    Zhuolin Xie
    Chang Li
    Chun Xu
    Cheng Ding
    Sheng Ju
    Jun Chen
    Zihan Cui
    Chen Chen
    Biao Gu
    Tengteng Wei
    Jun Zhao
    Journal of Molecular Histology, 2022, 53 : 657 - 667
12345